DK145666C - Fremgangsmaade til fremstilling af 17alfa-(3-jodbenzoyloxy)-9alfa-chlor-4-pregnen-3,20-dioner eller deres d-homoanaloge - Google Patents

Fremgangsmaade til fremstilling af 17alfa-(3-jodbenzoyloxy)-9alfa-chlor-4-pregnen-3,20-dioner eller deres d-homoanaloge

Info

Publication number
DK145666C
DK145666C DK477778A DK477778A DK145666C DK 145666 C DK145666 C DK 145666C DK 477778 A DK477778 A DK 477778A DK 477778 A DK477778 A DK 477778A DK 145666 C DK145666 C DK 145666C
Authority
DK
Denmark
Prior art keywords
iodbenzoyloxy
9alfa
17alfa
diones
chlor
Prior art date
Application number
DK477778A
Other languages
Danish (da)
English (en)
Other versions
DK145666B (da
DK477778A (da
Inventor
Ulrich Kerb
Manfred Stahnke
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772748443 external-priority patent/DE2748443A1/de
Priority claimed from DE2748442A external-priority patent/DE2748442C3/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK477778A publication Critical patent/DK477778A/da
Publication of DK145666B publication Critical patent/DK145666B/da
Application granted granted Critical
Publication of DK145666C publication Critical patent/DK145666C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK477778A 1977-10-26 1978-10-26 Fremgangsmaade til fremstilling af 17alfa-(3-jodbenzoyloxy)-9alfa-chlor-4-pregnen-3,20-dioner eller deres d-homoanaloge DK145666C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19772748443 DE2748443A1 (de) 1977-10-26 1977-10-26 17alpha-(3-jodbenzoyloxy)-9alpha- chlor-d-homo-4-pregnen-3.20-dione und verfahren zu ihrer herstellung
DE2748442A DE2748442C3 (de) 1977-10-26 1977-10-26 17α-(3-Jodbenzoyloxy)-9α -chlor4-pregnen-3.20-dione, Zwischenprodukte und Verfahren zu ihrer Herstellung, 9α -chlor-17α, 21-dihydroxy-1,4-pregnadien-3,20-dion und dieses enthaltende Arzneimittel
DE2748442 1977-10-26
DE2748443 1977-10-26

Publications (3)

Publication Number Publication Date
DK477778A DK477778A (da) 1979-04-27
DK145666B DK145666B (da) 1983-01-17
DK145666C true DK145666C (da) 1983-07-18

Family

ID=25772982

Family Applications (1)

Application Number Title Priority Date Filing Date
DK477778A DK145666C (da) 1977-10-26 1978-10-26 Fremgangsmaade til fremstilling af 17alfa-(3-jodbenzoyloxy)-9alfa-chlor-4-pregnen-3,20-dioner eller deres d-homoanaloge

Country Status (6)

Country Link
EP (1) EP0001737B1 (en, 2012)
JP (1) JPS5470253A (en, 2012)
BG (1) BG28719A3 (en, 2012)
DD (1) DD138981A5 (en, 2012)
DK (1) DK145666C (en, 2012)
HU (1) HU177759B (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
US4197406A (en) * 1978-05-12 1980-04-08 Hoffmann-La Roche Inc. D-Homosteroids
DE3680788D1 (de) * 1985-10-23 1991-09-12 Upjohn Co Angiostatische steroide.
EP3006453A1 (en) 2014-10-08 2016-04-13 Cosmo Technologies Ltd. 17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1081888B (de) * 1956-12-31 1960-05-19 Searle & Co Verfahren zur Herstellung von ?-3-Keto-9 ª‡-halogensteroiden

Also Published As

Publication number Publication date
JPS5470253A (en) 1979-06-05
EP0001737B1 (de) 1981-01-07
HU177759B (en) 1981-12-28
DK145666B (da) 1983-01-17
EP0001737A1 (de) 1979-05-16
JPS6227076B2 (en, 2012) 1987-06-12
BG28719A3 (en) 1980-06-16
DD138981A5 (de) 1979-12-05
DK477778A (da) 1979-04-27

Similar Documents

Publication Publication Date Title
DK150204C (da) Analogifremgangsmaade til fremstilling af dipeptidyl-agmatiner eller deres hydrochlorider
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK42480A (da) Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
NL7807234A (nl) Luchtige suikerwaren en werkwijze ter bereiding daar- van.
DK364579A (da) Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
DK148477C (da) Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK153950C (da) Analogifremgangsmaade til fremstilling af quinolylguanidiner eller derivater deraf
DK146281C (da) Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf
DK150479C (da) Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin
DK142080C (da) Fremgangsmaade til fremstilling af 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-oner
DK165687C (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner
DK162448C (da) Fremgangsmaade til fremstilling af 17beta-hydroxy-3-oxo-17alfa-pregn-4-en-21-carboxylsyre delta-lacton eller 17beta-hydroxy-3-oxo-17alfa-pregna-4,6-dien-21-carboxylsyre delta-lacton
DK149088C (da) Fremgangsmaade til fremstilling af 1,3-dihydroxy-2-aminopropan
DK158837C (da) Fremgangsmaade til fremstilling af p-hydroxyphenylglycin.
DK454579A (da) Fremgangsmaade til fremstilling af 6-piperidino-2,4-diaminopyrimidin-3-oxid
DK149628C (da) Analogifremgangsmaade til fremstilling af 8-substitueret-4ae-amino-makrolider eller syreadditionssalte deraf
DK145666C (da) Fremgangsmaade til fremstilling af 17alfa-(3-jodbenzoyloxy)-9alfa-chlor-4-pregnen-3,20-dioner eller deres d-homoanaloge
DK146390C (da) Analogifremgangsmaade til fremstilling af 25-halogen-cholest-5-en-3beta,22-dioler eller estere deraf
DK57778A (da) Fremgangsmaade til fremstilling af 1,3-disubstitueret urinstof eller 2-thioruinstof
DK147198C (da) Analogifremgangsmaade til fremstilling af 9-hydroxyethoxymethylguanin-monophosphat eller salte deraf
DK142986C (da) Fremgangsmaade til fremstilling af 2,6,6-trimethyl-2-cyanomethyl-tetrahydropyran eller 2-methyl-2-cyanomethyl-5-isopropyl-tetrahydrofuran eller blandinger heraf
DK149607C (da) Fremgangsmaade til fremstilling af l-2,4-diaminosmaersyre eller l-4-amino-2-hydroxysmaersyre
DK150487C (da) Analogifremgangsmaade til fremstilling af triazolo-thieno-diazepin-1-oner eller alkalimetalsalte deraf
DK153786C (da) Analogifremgangsmaade til fremstilling af 3-cyan-n-(n,n-dimethylaminopropyl)-iminodibenzyl eller syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed